# Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study

> **NCT01944371** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 30 (actual)

## Conditions studied

- HIV
- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Disulfiram

## Key facts

- **NCT ID:** NCT01944371
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-05-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01944371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01944371, "Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01944371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*